ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia-Reference-Cited by-同舟云学术

ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia

Published:2017-05-18 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Micol Jean-Baptiste,Pastore Alessandro,Inoue Daichi,Duployez Nicolas^ORCID,Kim Eunhee,Lee Stanley Chun-Wei,Durham Benjamin H.,Chung Young Rock,Cho Hana,Zhang Xiao Jing,Yoshimi Akihide,Krivtsov Andrei,Koche Richard,Solary Eric,Sinha Amit,Preudhomme Claude,Abdel-Wahab Omar

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms15429.pdf

Reference68 articles.

1. Ernst, P. et al. Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev. Cell 6, 437–443 (2004).

2. Klauke, K. et al. Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation. Nat. Cell Biol. 15, 353–362 (2013).

3. Hidalgo, I. et al. Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest. Cell Stem Cell 11, 649–662 (2012).

4. Xie, H. et al. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. Cell Stem Cell 14, 68–80 (2014).

5. Lee, S. C. et al. Polycomb repressive complex 2 component Suz12 is required for hematopoietic stem cell function and lymphopoiesis. Blood 126, 167–175 (2015).

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impaired DNA damage response and inflammatory signalling underpins hematopoietic stem cell defects inGata2haploinsufficiency;2024-08-21

2. Identification of epigenetic modifiers essential for growth and survival of AML1/ETO‐positive leukemia;International Journal of Cancer;2024-08-15

3. RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core‐binding factor‐acute myeloid leukaemia;British Journal of Haematology;2024-05-27

4. Additional Sex Combs-like Family Associated with Epigenetic Regulation;International Journal of Molecular Sciences;2024-05-08

5. Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications;American Journal of Hematology;2024-04-13